UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Combination of Fosfomycin plus Meropenem Is Synergistic for Pseudomonas aeruginosa PAO1 in a Hollow-Fiber Infection Model

Antimicrobial agents and chemotherapy, 2018-12, Vol.62 (12)

2018

Volltextzugriff (PDF)

Impact of Bolus Dosing versus Continuous Infusion of Piperacillin and Tazobactam on the Development of Antimicrobial Resistance in Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy, 2013-12, Vol.57 (12), p.5811-5819

2013

Volltextzugriff (PDF)

Individualization of piperacillin dosing for critically ill patients: dosing software to optimize antimicrobial therapy

Antimicrobial agents and chemotherapy, 2014-07, Vol.58 (7), p.4094-4102

2014

Volltextzugriff (PDF)

Tools for the Individualized Therapy of Teicoplanin for Neonates and Children

Antimicrobial agents and chemotherapy, 2017-10, Vol.61 (10)

2017

Volltextzugriff (PDF)

Developing New Drugs for Mycobacterium tuberculosis Therapy: What Information Do We Get from Preclinical Animal Models?

Antimicrobial agents and chemotherapy, 2020-11, Vol.64 (12)

2020

Volltextzugriff (PDF)

A proof of concept reinforcement learning based tool for non parametric population pharmacokinetics workflow optimization

Journal of pharmacokinetics and pharmacodynamics, 2023-02, Vol.50 (1), p.33-43

2023

Volltextzugriff (PDF)

Population pharmacokinetics and pharmacodynamics of teicoplanin in neonates: making better use of C-reactive protein to deliver individualized therapy

Journal of antimicrobial chemotherapy, 2016-11, Vol.71 (11), p.3168-3178

2016

Volltextzugriff (PDF)

How to design a study to evaluate therapeutic drug monitoring in infectious diseases?

Clinical microbiology and infection, 2020-08, Vol.26 (8), p.1008-1016

2020

Volltextzugriff (PDF)

The exciting future of antifungal therapy

European journal of clinical microbiology & infectious diseases, 2000-12, Vol.19 (12), p.897-914

2000

Volltextzugriff (PDF)

Roles of LysP and CadC in mediating the lysine requirement for acid induction of the Escherichia coli cad operon

Journal of Bacteriology, 1994-06, Vol.176 (11), p.3278-3285

1994

Volltextzugriff (PDF)

Kinetics of expression of the Escherichia coli cad operon as a function of pH and lysine

Journal of Bacteriology, 1996-09, Vol.178 (18), p.5522-5528

1996

Volltextzugriff (PDF)

Bacteriophage control of Shiga toxin 1 production and release by Escherichia coli

Molecular microbiology, 2002-05, Vol.44 (4), p.957-970

2002

Volltextzugriff (PDF)

Role of RopB in Growth Phase Expression of the SpeB Cysteine Protease of Streptococcus pyogenes

Journal of Bacteriology, 2003-09, Vol.185 (17), p.5166-5174

2003

Volltextzugriff (PDF)

Functional and genetic analysis of regulatory regions of coliphage H‐19B: location of shiga‐like toxin and lysis genes suggest a role for phage functions in toxin release

Molecular microbiology, 1998-06, Vol.28 (6), p.1255-1267

1998

Volltextzugriff (PDF)

N‐mediated transcription antitermination in lambdoid phage H‐19B is characterized by alternative NUT RNA structures and a reduced requirement for host factors

Molecular microbiology, 2000-12, Vol.38 (5), p.1074-1085

2000

Volltextzugriff (PDF)

The newly characterized colicin Y provides evidence of positive selection in pore-former colicin diversification

Microbiology (Society for General Microbiology), 2000-07, Vol.146 ( Pt 7), p.1671

2000

Volltextzugriff (PDF)

A branch in the ToxR regulatory cascade of Vibrio cholerae revealed by characterization of toxT mutant strains

Molecular microbiology, 1997-01, Vol.23 (2), p.323-331

1997

Volltextzugriff (PDF)

Influence of renal function estimation on pharmacokinetic modeling of vancomycin in elderly patients

Antimicrobial agents and chemotherapy, 2015-06, Vol.59 (6), p.2986-2994

2015

Volltextzugriff (PDF)

The Combination of Fosfomycin plus Meropenem Is Synergistic for Pseudomonas aeruginosa PAO1 in a Hollow-Fiber Infection Model

Antimicrobial agents and chemotherapy, 2018-11, Vol.62 (12)

2018

Volltextzugriff (PDF)

Arrangement and functional identification of genes in the regulatory region of lambdoid phage H-19B, a carrier of a Shiga-like toxin

Gene, 1998-11, Vol.223 (1-2), p.105-113

1998

Volltextzugriff (PDF)

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions

The Lancet infectious diseases, 2014-06, Vol.14 (6), p.498-509

2014

Volltextzugriff (PDF)

Fluconazole prophylaxis in the very low birth weight infant: not ready for prime time

Pediatrics (Evanston), 2001-02, Vol.107 (2), p.404-405

2001

Volltextzugriff (PDF)

Cervical shedding of HIV-1 RNA among women with low levels of viremia while receiving highly active antiretroviral therapy

Journal of acquired immune deficiency syndromes (1999), 2007-01, Vol.44 (1), p.38-42

2007

Volltextzugriff (PDF)

Pharmacokinetics, Safety, and Tolerability of Caspofungin in Children and Adolescents

Antimicrobial Agents and Chemotherapy, 2005-11, Vol.49 (11), p.4536-4545

2005

Volltextzugriff (PDF)

Individualization of Piperacillin Dosing for Critically III Patients: Dosing Software To Optimize Antimicrobial Therapy

Antimicrobial agents and chemotherapy, 2014, Vol.58 (7), p.4094-4102

2014

Volltextzugriff (PDF)

1 – 25 von 625

Suche als RSS-Feed

Aktive Filter

ThemaAnimals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(560)
Mit Volltextzugriff
(508)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Combination of Fosfomycin plus Meropenem Is Synergistic for Pseudomonas aeruginosa PAO1 in a Hollow-Fiber Infection Model

Impact of Bolus Dosing versus Continuous Infusion of Piperacillin and Tazobactam on the Development of Antimicrobial Resistance in Pseudomonas aeruginosa

Individualization of piperacillin dosing for critically ill patients: dosing software to optimize antimicrobial therapy

Tools for the Individualized Therapy of Teicoplanin for Neonates and Children

Developing New Drugs for Mycobacterium tuberculosis Therapy: What Information Do We Get from Preclinical Animal Models?

A proof of concept reinforcement learning based tool for non parametric population pharmacokinetics workflow optimization

Population pharmacokinetics and pharmacodynamics of teicoplanin in neonates: making better use of C-reactive protein to deliver individualized therapy

How to design a study to evaluate therapeutic drug monitoring in infectious diseases?

The exciting future of antifungal therapy

Roles of LysP and CadC in mediating the lysine requirement for acid induction of the Escherichia coli cad operon

Kinetics of expression of the Escherichia coli cad operon as a function of pH and lysine

Bacteriophage control of Shiga toxin 1 production and release by Escherichia coli

Role of RopB in Growth Phase Expression of the SpeB Cysteine Protease of Streptococcus pyogenes

Functional and genetic analysis of regulatory regions of coliphage H‐19B: location of shiga‐like toxin and lysis genes suggest a role for phage functions in toxin release

N‐mediated transcription antitermination in lambdoid phage H‐19B is characterized by alternative NUT RNA structures and a reduced requirement for host factors

The newly characterized colicin Y provides evidence of positive selection in pore-former colicin diversification

A branch in the ToxR regulatory cascade of Vibrio cholerae revealed by characterization of toxT mutant strains

Influence of renal function estimation on pharmacokinetic modeling of vancomycin in elderly patients

The Combination of Fosfomycin plus Meropenem Is Synergistic for Pseudomonas aeruginosa PAO1 in a Hollow-Fiber Infection Model

Arrangement and functional identification of genes in the regulatory region of lambdoid phage H-19B, a carrier of a Shiga-like toxin

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions

Fluconazole prophylaxis in the very low birth weight infant: not ready for prime time

Cervical shedding of HIV-1 RNA among women with low levels of viremia while receiving highly active antiretroviral therapy

Pharmacokinetics, Safety, and Tolerability of Caspofungin in Children and Adolescents

Individualization of Piperacillin Dosing for Critically III Patients: Dosing Software To Optimize Antimicrobial Therapy

Aktive Filter

Suchergebnisse filtern